Abbvie
Skyrizi
Manufacturer:
Abbvie
Name:
Skyrizi
HCPCS Code Descriptor:
Injection, risankizumab-rzaa, intravenous, 1 mg
Category:
J Code
HCPCS:
J2327
NDC(s):
00074-1050-01, 00074-1065-01, 00074-1070-01, 00074-2100-01, 00074-5015-01
Primary Type:
Immunology:Anti-TNF
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
Skyrizi is an Immunology:Anti-TNF drug manufactured by Abbvie and administered via the Subcutaneous route of administration. The J Code: J2327 is aligned to the drug Skyrizi.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/23
HCPCS Effective Date:
1/1/23
HCPCS Short Description:
Inj risankizumab-rzaa 1 mg
Billing and Coding Guide:
https://www.skyrizihcp.com/content/dam/skyrizihcpivy/docs/billing-coding-guide.pdf
Patient Assistance:
https://www.abbvie.com/patients/patient-assistance.html